1. Preliminary Results that Assess Metformin Treatment in a Preclinical Model of Pancreatic Cancer Using Simultaneous [18F]FDG PET and acidoCEST MRI
    Joshua M. Goldenberg et al, 2018, Mol Imaging Biol CrossRef
  2. Targeting tumor-associated acidity in cancer immunotherapy
    Ruben Lacroix et al, 2018, Cancer Immunol Immunother CrossRef
  3. New strategies for targeting glucose metabolism-mediated acidosis for colorectal cancer therapy
    Gang Wang et al, 2018, J Cell Physiol CrossRef
  4. Emerging Technologies to Image Tissue Metabolism
    Vasilis Ntziachristos et al, 2018, Cell Metabolism CrossRef
  5. Inhibitory ASIC2-mediated calcineurin/NFAT against colorectal cancer by triterpenoids extracted from Rhus chinensis Mill
    Gang Wang et al, 2019, Journal of Ethnopharmacology CrossRef
  6. Imaging tumor acidosis: a survey of the available techniques for mapping in vivo tumor pH
    Annasofia Anemone et al, 2019, Cancer Metastasis Rev CrossRef
  7. Contradiction between amide‐CEST signal and pH in breast cancer explained with metabolic MRI
    Erwin Krikken et al, 2019, NMR in Biomedicine CrossRef
  8. Triterpenoids Extracted from Rhus chinensis Mill Act Against Colorectal Cancer by Inhibiting Enzymes in Glycolysis and Glutaminolysis: Network Analysis and Experimental Validation
    Gang Wang et al, 2019, Nutrition and Cancer CrossRef
  9. Hydrogen Ion Dynamics of Cancer and a New Molecular, Biochemical and Metabolic Approach to the Etiopathogenesis and Treatment of Brain Malignancies
    Salvador Harguindey et al, 2019, IJMS CrossRef
  10. null
    Tomas Koltai et al, 2020 CrossRef
  11. Non-invasive Investigation of Tumor Metabolism and Acidosis by MRI-CEST Imaging
    Lorena Consolino et al, 2020, Front. Oncol. CrossRef
  12. Dichloroacetate prevents TGFβ-induced epithelial-mesenchymal transition of retinal pigment epithelial cells
    Dhaval Shukal et al, 2020, Experimental Eye Research CrossRef
  13. The effects and mechanisms of isoliquiritigenin loaded nanoliposomes regulated AMPK/mTOR mediated glycolysis in colorectal cancer
    Gang Wang et al, 2020, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  14. A fast multislice sequence for 3D MRI‐CEST pH imaging
    Daisy Villano et al, 2020, Magn Reson Med CrossRef
  15. Sarcoma treatment in the era of molecular medicine
    Thomas GP Grünewald et al, 2020, EMBO Mol Med CrossRef
  16. Clinical value and potential association of Rab1A and FoxM1 aberrant expression in colorectal cancer
    Menglin Xu et al, 2020, Sci Rep CrossRef
  17. Tumour acidosis evaluated in vivo by MRI-CEST pH imaging reveals breast cancer metastatic potential
    Annasofia Anemone et al, 2020, Br J Cancer CrossRef
  18. Repurposing Clinical Agents for Chemical Exchange Saturation Transfer Magnetic Resonance Imaging: Current Status and Future Perspectives
    Zelong Chen et al, 2020, Pharmaceuticals CrossRef
  19. Perspectives on the Role of Isoliquiritigenin in Cancer
    Kai-Lee Wang et al, 2021, Cancers CrossRef
  20. Evaluation of a similarity anisotropic diffusion denoising approach for improving in vivo CEST‐MRI tumor pH imaging
    Feriel Romdhane et al, 2021, Magn Reson Med CrossRef
  21. An ultrasound-guided injection method for a syngeneic orthotopic murine model of breast cancer
    Francesca La Cava et al, 2021, Lab Anim CrossRef
  22. GlucoCEST MRI for the Evaluation Response to Chemotherapeutic and Metabolic Treatments in a Murine Triple-Negative Breast Cancer: A Comparison with[18F]F-FDG-PET
    Martina Capozza et al, 2021, Mol Imaging Biol CrossRef
  23. Impact of Inhibition of the Mitochondrial Pyruvate Carrier on the Tumor Extracellular pH as Measured by CEST-MRI
    Chloé Buyse et al, 2021, Cancers CrossRef
  24. null
    Marie-France Penet et al, 2021 CrossRef
  25. Metformin and sodium dichloroacetate effects on proliferation, apoptosis, and metabolic activity tested alone and in combination in a canine prostate and a bladder cancer cell line.
    Katharina Klose et al, 2021, PLoS One CrossRef
  26. Simultaneous Evaluations of pH and Enzyme Activity with a CEST MRI Contrast Agent
    Chathuri J. Kombala et al, 2021, ACS Sens. CrossRef
  27. Development of a Nanoscale Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Contrast Agent That Measures pH
    Chathuri J. Kombala et al, 2021, ACS Nano CrossRef
  28. Tumor Hypoxia Heterogeneity Affects Radiotherapy: Inverse-Percolation Shell-Model Monte Carlo Simulations
    Argyris Dimou et al, 2022, Entropy CrossRef
  29. Acidic Tumor Microenvironment Promotes Pancreatic Cancer through miR-451a/MEF2D Axis
    Jingyong Xu et al, 2022, Journal of Oncology CrossRef
  30. What do we know about dynamic glucose-enhanced (DGE) MRI and how close is it to the clinics? Horizon 2020 GLINT consortium report
    Mina Kim et al, 2022, Magn Reson Mater Phy CrossRef
  31. Magnetic Resonance pH Imaging in Stroke – Combining the Old With the New
    James R. Larkin et al, 2022, Front. Physiol. CrossRef
  32. PI3K-AKT Pathway Modulation by Thymoquinone Limits Tumor Growth and Glycolytic Metabolism in Colorectal Cancer
    Shahid Karim et al, 2022, IJMS CrossRef
  33. New tools to investigate tumor metabolism by NMR/MRI
    Silvio Aime et al, 2022, Journal of Magnetic Resonance CrossRef
  34. A snapshot of the vast array of diamagnetic CEST MRI contrast agents
    Dario Livio Longo et al, 2022, NMR in Biomedicine CrossRef
  35. DDR1 promotes LoVo cell proliferation by regulating<?A3B2 ACK?>energy metabolism
    Bin Xiong et al, 2022, ABBS CrossRef
  36. Tumor Biochemical Heterogeneity and Cancer Radiochemotherapy: Network Breakdown Zone-Model
    Argyris Dimou et al, 2022, Entropy CrossRef
  37. Rational Design of pH-Activated Upconversion Luminescent Nanoprobes for Bioimaging of Tumor Acidic Microenvironment and the Enhancement of Photothermal Therapy
    Baojin Tan et al, 2022, Acta Biomaterialia CrossRef
  38. In Vivo MRI-CEST Tumor pH Imaging Detects Resistance to Proton Pump Inhibitors in Human Prostate Cancer Murine Models
    Pietro Irrera et al, 2022, Cancers CrossRef
  39. Monitor Tumor pHe and Response Longitudinally during Treatment Using CEST MRI-Detectable Alginate Microbeads
    Peng Xiao et al, 2022, ACS Appl. Mater. Interfaces CrossRef
  40. Effect of Esomeprazole Treatment on Extracellular Tumor pH in a Preclinical Model of Prostate Cancer by MRI-CEST Tumor pH Imaging
    Pietro Irrera et al, 2022, Metabolites CrossRef
  41. null
    Dario Livio Longo et al, 2023 CrossRef
  42. Intraperitoneal Delivery of Iopamidol to Assess Extracellular pH of Orthotopic Pancreatic Tumor Model by CEST-MRI
    Bruna Victorasso Jardim-Perassi et al, 2023, Contrast Media & Molecular Imaging CrossRef
  43. In-vivo magnetic resonance spectroscopy of lactate as a non-invasive biomarker of dichloroacetate activity in cancer and non-cancer central nervous system disorders
    David O. Kamson et al, 2023, Front. Oncol. CrossRef
  44. CircRNAs: emerging factors for regulating glucose metabolism in colorectal cancer
    Yulin Liu et al, 2023, Clin Transl Oncol CrossRef
  45. YY1 lactylation in microglia promotes angiogenesis through transcription activation-mediated upregulation of FGF2
    Xiaotang Wang et al, 2023, Genome Biol CrossRef
  46. null
    Tomas Koltai et al, 2023 CrossRef
  47. Assessing the Therapeutic Efficacy of Proton Transport Inhibitors in a Triple-Negative Breast Cancer Murine Model with Magnetic Resonance Imaging–Chemical Exchange Saturation Transfer Tumor pH Imaging
    Chetan Dhakan et al, 2023, Metabolites CrossRef
  48. In vivo lymph node CEST‐Dixon MRI in breast cancer patients with metastatic lymph node involvement
    Manus J. Donahue et al, 2024, Magnetic Resonance in Med CrossRef
  49. L-DOS47 Elevates Pancreatic Cancer Tumor pH and Enhances Response to Immunotherapy
    Bruna Victorasso Jardim-Perassi et al, 2024, Biomedicines CrossRef